Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?

BACKGROUND: Women with polycystic ovary syndrome (PCOS) are at increased risk for cardiovascular (CV) and metabolic disorders. There is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy. In randomized trials, the administration of metform...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gharakhani, Mohsen, Neghab, Nosrat, Farimani, Marzie
Format: Artigo
Idioma:Inglês
Publicat: Royan Institute 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4059955/
https://ncbi.nlm.nih.gov/pubmed/24963365
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars